Across TCGA pan-cancer cohorts, FGF7P5 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of FGF7P5’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where FGF7P5 RNA is repressed in tumor relative to normal tissue. In most cancer types FGF7P5 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD are the cancer types where FGF7P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FGF7P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	−0.048	.023	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: FGF7P5 RNA expression & survival · all FGF7P5 data types